112 related articles for article (PubMed ID: 9767280)
1. Altered expression of the alpha2 laminin chain in psoriatic skin: the effect of treatment with cyclosporin.
Toti P; Pellegrino M; Villanova M; Flori ML; Miracco C; Bartolommei S; Andreassi L
Br J Dermatol; 1998 Sep; 139(3):375-9. PubMed ID: 9767280
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1, B and A expression and cell turnover in psoriatic skin lesions before and after cyclosporin treatment.
Miracco C; Pellegrino M; Flori ML; Vatti R; Materno M; Andreassi L
Br J Dermatol; 2000 Nov; 143(5):950-6. PubMed ID: 11069501
[TBL] [Abstract][Full Text] [Related]
3. Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: successful disease control with cyclosporin.
Imanishi A; Tateishi C; Imanishi H; Sowa-Osako J; Koga H; Tsuruta D; Hashimoto T
J Dermatol; 2015 Apr; 42(4):394-7. PubMed ID: 25708520
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural findings and tumor necrosis factor-alpha and intercellular adhesion molecule-1 expression in psoriasis patients before and after oral cyclosporin A therapy.
Eşrefoğlu M; Gül M; Seyhan M
Ultrastruct Pathol; 2006; 30(1):95-102. PubMed ID: 16517475
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis and cyclosporin: immunohistochemical aspects of the basement membrane.
Mondello MR; Califano L; Cannavò SP; Di Mauro D; Guarneri B; Magaudda L; Pergolizzi S; Santoro G; Vaccaro M
Acta Derm Venereol Suppl (Stockh); 1994; 186():96-8. PubMed ID: 8073854
[TBL] [Abstract][Full Text] [Related]
6. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis.
Otkjaer K; Kragballe K; Funding AT; Clausen JT; Noerby PL; Steiniche T; Iversen L
Br J Dermatol; 2005 Nov; 153(5):911-8. PubMed ID: 16225599
[TBL] [Abstract][Full Text] [Related]
7. Colocalization of multiple laminin isoforms predominantly beneath hemidesmosomes in the upper lamina densa of the epidermal basement membrane.
McMillan JR; Akiyama M; Nakamura H; Shimizu H
J Histochem Cytochem; 2006 Jan; 54(1):109-18. PubMed ID: 16174790
[TBL] [Abstract][Full Text] [Related]
8. Expression of the psoriasis-associated antigen, Pso p27, is inhibited by cyclosporin A.
Dalaker M; Jacobsen T; Lysvand H; Iversen OJ
Acta Derm Venereol; 1999 Jul; 79(4):281-4. PubMed ID: 10429984
[TBL] [Abstract][Full Text] [Related]
9. Changes in the distribution of laminin alpha1 chain in psoriatic skin: immunohistochemical study using confocal laser scanning microscopy.
Vaccaro M; Magaudda L; Cutroneo G; Trimarchi F; Barbuzza O; Guarneri F; Guarneri B
Br J Dermatol; 2002 Mar; 146(3):392-8. PubMed ID: 11952538
[TBL] [Abstract][Full Text] [Related]
10. Increased insulin-like growth factor binding protein-3 expression level in psoriatic tissue before and after systemic treatment with cyclosporine A and methotrexate.
Ozden MG; Ilter N; Suer OE; Solaktekin N; Gürer MA
Int J Dermatol; 2008 Nov; 47(11):1177-83. PubMed ID: 18986456
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with the use of cyclosporin A in psoriasis. Results of a retrospective study.
Ojeda R; Sánchez Regaña M; Massana J; Oliete R; Umbert P
J Dermatolog Treat; 2005; 16(4):238-41. PubMed ID: 16249146
[TBL] [Abstract][Full Text] [Related]
12. Basement membrane alterations in psoriasis are accompanied by epidermal overexpression of MMP-2 and its inhibitor TIMP-2.
Fleischmajer R; Kuroda K; Hazan R; Gordon RE; Lebwohl MG; Sapadin AN; Unda F; Iehara N; Yamada Y
J Invest Dermatol; 2000 Nov; 115(5):771-7. PubMed ID: 11069613
[TBL] [Abstract][Full Text] [Related]
13. Dimethylfumarate for psoriasis: Pronounced effects on lesional T-cell subsets, epidermal proliferation and differentiation, but not on natural killer T cells in immunohistochemical study.
Bovenschen HJ; Langewouters AM; van de Kerkhof PC
Am J Clin Dermatol; 2010; 11(5):343-50. PubMed ID: 20553063
[TBL] [Abstract][Full Text] [Related]
14. The use of cyclosporin in a child with generalized pustular psoriasis.
Alli N; Güngör E; Karakayali G; Lenk N; Artüz F
Br J Dermatol; 1998 Oct; 139(4):754-5. PubMed ID: 9892934
[No Abstract] [Full Text] [Related]
15. Differences in basement membrane zone components of normal conjunctiva, conjunctiva in glaucoma and normal skin.
Messmer EM; Valet VM; Kampik A
Acta Ophthalmol; 2012 Sep; 90(6):e476-81. PubMed ID: 22900849
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin in childhood psoriasis.
Perrett CM; Ilchyshyn A; Berth-Jones J
J Dermatolog Treat; 2003 Jun; 14(2):113-8. PubMed ID: 12775319
[TBL] [Abstract][Full Text] [Related]
17. Influence of systemic cyclosporin A on interleukin-2 and epidermal growth factor receptor expression in psoriatic skin lesions.
Horroccks A; Ormerod AD; Duncan JI; Thomson AW
Clin Exp Immunol; 1989 Nov; 78(2):166-71. PubMed ID: 12412743
[TBL] [Abstract][Full Text] [Related]
18. Use of basiliximab as a cyclosporin-sparing agent in palmoplantar pustular psoriasis with myalgia as an adverse effect.
Bell HK; Parslew RA
Br J Dermatol; 2002 Sep; 147(3):606-7. PubMed ID: 12207613
[No Abstract] [Full Text] [Related]
19. [Quantitative changes in CD4+ and CD8+ T-lymphocytes in the skin of patients with psoriasis treated with cyclosporin A].
Adamicová K; Fetisovová Z; Cingel P; Péc J; Parobeková K; Chromej I
Cesk Patol; 2001 Nov; 37(4):154-7. PubMed ID: 11813632
[TBL] [Abstract][Full Text] [Related]
20. Downregulation and altered spatial pattern of caveolin-1 in chronic plaque psoriasis.
Campbell L; Laidler P; Watson RE; Kirby B; Griffiths CE; Gumbleton M
Br J Dermatol; 2002 Oct; 147(4):701-9. PubMed ID: 12366416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
